State Street Corp Dynavax Technologies Corp Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Dynavax Technologies Corp stock. As of the latest transaction made, State Street Corp holds 7,794,524 shares of DVAX stock, worth $104 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,794,524
Previous 7,690,274
1.36%
Holding current value
$104 Million
Previous $85.7 Million
16.19%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$292 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$237 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$122 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$87.5 Million5.31% of portfolio
-
Chicago Capital, LLC5.38MShares$71.7 Million1.84% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.69B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...